Drug and Alcohol Behaviors With Direct-Acting Antiviral Treatment in HCV
Researchers found data that showed patients who have or who are injecting drugs would benefit from treatment for HCV with direct-acting antivirals.
Researchers found data that showed patients who have or who are injecting drugs would benefit from treatment for HCV with direct-acting antivirals.
At centers in Asia, Europe, and the Americas, investigators conducted a randomized controlled trial of patients with chronic hepatitis B virus infection to assess the long-term effects of entecavir.
Investigators found that young age, high HCV viral load, and HCV/HIV co-infection were the factors associated with an increased transmission risk.
Researchers found data that showed entecavir is safe in the treatment of hepatitis B virus in patients who are undergoing hemodialysis.
Researchers found data that showed early initiation of antiviral therapy with lamivudine in infants with hepatitis B caused a rapid loss of HBsAg.